The Parkinson’s disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neurons

These results indicate that the reduction of catB function negatively impacts lysosomal pathways associated with PD pathogenesis, while conversely catB activation could promote the clearance of pathogenic alpha-synuclein.

Authors

Institutions

Publication Details

Journal
Molecular Neurodegeneration
Published
2024-11-24
DOI
https://doi.org/10.1186/s13024-024-00779-9
Citations
26
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
9.60

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Parkinson’s disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neurons

Konstantin A. Senkevich, Austen J. Milnerwood, Farnaz Asayesh, Stanley Fahn et al.
26 citations
Molecular Neurodegeneration
Parkinson's Disease Mechanisms and Treatments
9.60
article

The Parkinson’s disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neurons

Konstantin A. Senkevich, Austen J. Milnerwood, Farnaz Asayesh, Stanley Fahn, Jace Jones-Tabah, Thomas M. Durcan, Esther del Cid‐Pellitero, Carol X.‐Q. Chen, Cheryl Waters, Edward A. Fon, Jennifer A. Ruskey, Oury Monchi, Sharon Hassin‐Baer, Roy N. Alcalay, Daria Nikanorova, Irina Miliukhina, Wen Luo, Dan Spiegelman, Lior Greenbaum, Narges Abdian, Taylor Goldsmith, Nicolas Dupré, Thomas Goiran, Yves A Dauvilliers, Ziv Gan‐Or, Yuting Cousineau, Nathan Karpilovsky, Isabella Pietrantonio, Ghislaine Deyab, Jamil Ahmad, Alla Timofeeva, Zhipeng You, Anton Emelyanov, Sofya Pchelina, Kathy He
article en
26 citations

Abstract

These results indicate that the reduction of catB function negatively impacts lysosomal pathways associated with PD pathogenesis, while conversely catB activation could promote the clearance of pathogenic alpha-synuclein.

Molecular NeurodegenerationVol. 19(1)
Montreal Neurological Institute and Hospital (CA), Tel Aviv University (IL), Université de Montpellier (FR), Columbia University Irving Medical Center (US), First Pavlov State Medical University of St. Petersburg (RU), Tel Aviv Sourasky Medical Center (IL), Sheba Medical Center (IL), Institute of the Human Brain (RU), Hôpital Gui de Chauliac (FR), Institut Universitaire de Gériatrie de Montréal (CA), Bioinformatics Institute (RU), Université Laval (CA), McGill University (CA), Université de Montréal (CA)
Brookdale Foundation, McGill University, Parkinson's Foundation, Consortium canadien en neurodégénérescence associée au vieillissement, Parkinson Canada, Canada First Research Excellence Fund, National Institutes of Health, Canadian Institutes of Health Research
Good health and well-being
Openalex Percentile: Top 1%
Parkinson's Disease Mechanisms and Treatments
9.60
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.